254 results on '"Horai Y"'
Search Results
2. Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease
3. IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis
4. Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in Japan
5. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes
6. Review article: cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole
7. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort
8. IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis.
9. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort
10. Activation of Toll‐like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients
11. The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus
12. Activation of Toll‐like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
13. Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit: II. Multiple dose study
14. Individualized aminophylline therapy in patients with obstructive airway disease: Oral dosage prediction from an intravenous test dose
15. Pharmacokinetics and absolute bioavailability of carteolol, a new β-adrenergic receptor blocking agent
16. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit I. Single dose study
17. Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer
18. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration
19. FRI0027 MRI-Proven Bone Marrow Oedema at Baseline is the Strongest Predictor Toward the Development of Rapid Radiographic Progression at 1 Year in Patients with Early-Stage Rheumatoid Arthritis: Results from Nagasaki University Early Arthritis Cohort
20. FRI0048 MRI Bone Erosion at Baseline Predicts the Subsequent Radiographic Progression in Early-Stage RA Patients Who Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort
21. AB0665 Hypocholesterolemia at Diagnosis Can Predict the Relapse in Patients with Takayasu Arteritis
22. AB0180 The Role of Immune Regulation of CD4+CD52High T Cells in Systemic Lupus Erythematosus
23. FRI0429 Evaluation of Soluble α-Klotho in Neuropsychiatric Systemic Lupus Erythematosus
24. Ultrasonography as an additional item in the American College of Rheumatology classification of Sjogren's syndrome
25. SAT0261 Abatacept is A Suitable Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Anti-Ss-A Antibodies-Positive Rheumatoid Arthritis
26. AB1018 Articular Synovitis or Tenosynovitis - Which is More Involved toward Functional Disabilities in Patients with Rheumatoid Arthritis? Investigation of Wrist and Finger Joints by Ultrasound in Early-Stage Rheumatoid Arthritis
27. AB0219 Evaluation of the Japanese Patients with Rheumatoid Arthritis (RA) of RAPID Radiographic Progression (RRP) Treated with Synthetic Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Daily Practice: A Large-Scale Prospective Longitudinal Cohort Study
28. SAT0215 Ultrasound Disease Activity at 3 Months Predicts the Clinical Response at 6 Months of Patients with Rheumatoid Arthritis Treated by Biologic Disease Modifying Anti-Rheumatic Drugs
29. AB0646 Low Reactive Hyperemia Index Assessed by Endopat and High Circulating Level of Placenta Growth Factor, Growth Differentiation Factor-15 and Pentraxin-3 Reflect the Presence of Vasculopathy as Well as Progressive Disease Status in Patients with Systemic Sc
30. Synovial inflammation assessed by ultrasonography correlates with MRI-proven osteitis in patients with rheumatoid arthritis
31. Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion
32. FRI0084 The presence of magnetic resonance imaging-proven osteitis at entry predicts the development of rapid radiographic progression in patients with early rheumatoid arthritis
33. SAT0524 Automated Breast Volume Scanner (ABVS), a New Automated Ultrasonic Device, is Useful to Examine Joint Injury in Patients with Rheumatoid Arthritis
34. AB0482 Takayasu arteritis and hla-b52 allele: a single-centre analysis from japanese population
35. SAT0216 Low Reactive Hyperemia Index Assessed By Endo-Pat And High Serum Placenta Growth Factor Associate With Vasculopathy And Disease Progression In Patients With Systemic Sclerosis
36. AB0109 Regulatory mechanism and importance of thrombospondin-1 (tsp-1) expression in rheumatoid synovial tissues: analysis by immunohistochemistry, in vitro fibroblast-like synovial cell culture and clinical evaluation
37. THU0121 Characteristic of the Japanese Patients with Rheumatoid Arthritis (RA) of Rapid Radiographic Progression (RRP) Treated with Synthetic Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Daily Practice: A Large-Scale Prospective Longitudinal Cohort Study
38. SAT0489 The Severity of Synovial Inflammation Assessed by Musculoskeletal Ultrasonography Correlates with that of Osteitis Assessed by Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis
39. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM
40. Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease
41. Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population.
42. N-acetylation polymorphism of dapsone in a Japanese population.
43. N-acetylation phenotyping with dapsone in a mainland Chinese population.
44. Evidence for polymorphic oxidation of sparteine in Japanese subjects.
45. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
46. Hydralazine-induced peripheral neuropathy seen in a Japanese slow acetylator patient.
47. Rapid improvement of the Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: Results from an observational investigation of daily clinical practice
48. Comparison of Continuous Infusion Fentanyl or Ketamine Versus Thiopental-Determining the Mean Effective Serum Concentrations for Outpatient Surgery
49. Metoprolol oxidation in a Japanese population: evidence for only one poor metaboliser among 262 subjects [letter]
50. COMPARATIVE PHARMACOLOGY OF THE KETAMINE ISOMERS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.